ORIGINAL RESEARCH
Published on 10 May 2024
Activated interferon response from DNA damage in multiple myeloma cells contributes to the chemotherapeutic effects of anthracyclines
doi 10.3389/fonc.2024.1357996
- 736 views
- 1 citation
- Frontiers in Oncology
- Hematologic Malignancies
- Research Topics
- Editor's Challenge: Claudio Cerchione - Is it Time for a Targeted Therapy in Multiple Myeloma?
Editor's Challenge: Claudio Cerchione - Is it Time for a Targeted Therapy in Multiple Myeloma?
2,491
Total downloads
8,244
Total views and downloads
Submit your idea
You will be redirected to our submission process.
Articles
BRIEF RESEARCH REPORT
Published on 11 Apr 2024
Outcomes of percutaneous vertebroplasty in multiple myeloma: a tertiary neurosciences experience with long-term follow-up
doi 10.3389/fonc.2024.1291055
- 681 views
- 1 citation
REVIEW
Published on 26 Sep 2023
Matrix metalloproteinases and tissue inhibitors in multiple myeloma: promote or inhibit?
doi 10.3389/fonc.2023.1127407
- 2,568 views
- 5 citations
ORIGINAL RESEARCH
Published on 10 Nov 2022
Different expression patterns of VISTA concurrent with PD-1, Tim-3, and TIGIT on T cell subsets in peripheral blood and bone marrow from patients with multiple myeloma
doi 10.3389/fonc.2022.1014904
- 1,791 views
- 7 citations
Published in
Frontiers in Oncology
- Hematologic Malignancies
Impact
- 8,244Topic views
- 4,727Article views
- 2,491Article downloads